Lead Story Picture
A jury rejected claims against Pfizer Inc. in the first trial over alleged birth defect risks of its antidepressant Zoloft. (Credit: AP)

Jury Vindicates Pfizer In First Zoloft Birth Defect Trial

Pfizer Inc. notched a victory Friday in the first trial over the alleged birth defect risks of its blockbuster antidepressant drug Zoloft, when a state jury in St. Louis shot down claims by a woman who had argued that taking the medication during her pregnancy caused her son's heart problems. 

  • SEC's Freddie Mac Letdown Underscores Discovery Risks

    The ho-hum conclusion to the U.S. Securities and Exchange Commission's once high-flying case against former Freddie Mac executives offers the agency a painful lesson on how a once clearly stated fraud claim can become muddied and imprecise after years of discovery take their toll.

  • Fast-Track Bill Could Hit Speed Bump On Currency

    The introduction of a bill to renew the White House's fast-track trade negotiating authority was widely hailed Thursday as a bipartisan success, but lingering concerns over currency manipulation rules and procedural complications stemming from a suite of other trade measures could make final passage a heavy lift.

  • Ex-JPMorgan Adviser Charged With $20M Client Theft

    New York federal prosecutors on Thursday charged a former JPMorgan Chase & Co. investment adviser with stealing $20 million from clients and blowing the money on options trades and personal expenses.

  • Lawmakers Unveil New Bipartisan Fast-Track Bill

    The leaders of the Senate Finance Committee on Thursday introduced long-awaited legislation that will enable the White House to submit trade agreements for swift approval but also give lawmakers a larger role in the negotiating process, setting the stage for a high-stakes debate over the nation's trade policy.

  • EEOC Issues Proposed Regs On Wellness Programs, ADA

    The U.S. Equal Employment Opportunity Commission issued proposed regulations Thursday addressing how the Americans with Disabilities Act applies to corporate wellness programs, providing highly anticipated guidance on how to use financial incentives to encourage workers to participate in wellness programs without violating federal law.